These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17040195)

  • 1. Cholesterol absorption inhibitors as a therapeutic option for hypercholesterolaemia.
    Burnett JR; Huff MW
    Expert Opin Investig Drugs; 2006 Nov; 15(11):1337-51. PubMed ID: 17040195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol absorption inhibitors for the treatment of hypercholesterolaemia.
    Sudhop T; von Bergmann K
    Drugs; 2002; 62(16):2333-47. PubMed ID: 12396226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ezetimibe: rationale and role in the management of hypercholesterolemia.
    Yatskar L; Fisher EA; Schwartzbard A
    Clin Cardiol; 2006 Feb; 29(2):52-5. PubMed ID: 16506638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on patented cholesterol absorption inhibitors.
    Chhabria MT; Mahajan BM
    Expert Opin Ther Pat; 2009 Aug; 19(8):1083-107. PubMed ID: 19552506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ezetimibe: a selective cholesterol absorption inhibitor.
    Nutescu EA; Shapiro NL
    Pharmacotherapy; 2003 Nov; 23(11):1463-74. PubMed ID: 14620392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal sterol transporters and cholesterol absorption inhibition.
    Davis HR; Tershakovec AM; Tomassini JE; Musliner T
    Curr Opin Lipidol; 2011 Dec; 22(6):467-78. PubMed ID: 22101558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ezetimibe: cholesterol lowering and beyond.
    Bays HE; Neff D; Tomassini JE; Tershakovec AM
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):447-70. PubMed ID: 18402536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ezetimibe: a novel cholesterol-lowering agent that highlights novel physiologic pathways.
    Patel SB
    Curr Cardiol Rep; 2004 Nov; 6(6):439-42. PubMed ID: 15485605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cholesterol metabolism and therapeutic molecules.
    Charlton-Menys V; Durrington PN
    Exp Physiol; 2008 Jan; 93(1):27-42. PubMed ID: 18165431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ezetimibe (Schering-Plough).
    Meng CQ
    Curr Opin Investig Drugs; 2001 Mar; 2(3):389-92. PubMed ID: 11575710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Change in the cholesterol metabolism associated with the combined inhibition of synthesis and absorption].
    Márk L; Paragh G
    Orv Hetil; 2007 Apr; 148(14):627-32. PubMed ID: 17403635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of intestinal absorption of cholesterol by ezetimibe or bile acids by SC-435 alters lipoprotein metabolism and extends the lifespan of SR-BI/apoE double knockout mice.
    Braun A; Yesilaltay A; Acton S; Broschat KO; Krul ES; Napawan N; Stagliano N; Krieger M
    Atherosclerosis; 2008 May; 198(1):77-84. PubMed ID: 18054357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
    Daskalopoulou SS; Mikhailidis DP
    Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cholesterol absorption: targeting the intestine.
    Lee SD; Gershkovich P; Darlington JW; Wasan KM
    Pharm Res; 2012 Dec; 29(12):3235-50. PubMed ID: 22923351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid lowering activity of drugs affecting cholesterol absorption.
    Norata GD; Catapano AL
    Nutr Metab Cardiovasc Dis; 2004 Feb; 14(1):42-51. PubMed ID: 15053163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherosclerosis: cell biology and lipoproteins: cholesterol absorption inhibitors: gateway therapy for hypercholesterolaemia.
    Brown AJ
    Curr Opin Lipidol; 2002 Dec; 13(6):701-3. PubMed ID: 12441896
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimizing lipid lowering in patients at risk.
    Clark LT
    Clin Cardiol; 2004 Jun; 27(6 Suppl 3):III22-6. PubMed ID: 15239488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cholesterol absorption as a target for the treatment of hypercholesterolemia].
    Bitzur R; Cohen H; Harats D
    Harefuah; 2006 Nov; 145(11):831-5, 861, 860. PubMed ID: 17183957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapies on the horizon for cholesterol reduction.
    Brown WV
    Clin Cardiol; 2001 Aug; 24(8 Suppl):III24-7. PubMed ID: 11501600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.